Peptide receptor radionuclide therapy for ectopic Cushing’s syndrome caused by metastatic neuroendocrine neoplasms

Peptide receptor radionuclide therapy for ectopic Cushing’s syndrome caused by metastatic neuroendocrine neoplasms

Background: Metastatic gastroenteropancreatic neuroendocrine neoplasms (GEPNEN) can cause ectopic Cushing’s syndrome (ECS). ECS is highly morbid and medical therapy is complex and can be ineffective. Patients unsuitable for bilateral adrenalectomy (BA) have dismal outcomes. Peptide receptor radionuc...

Full description

Saved in:
Bibliographic Details
Main Authors: Emma Boehm, Terry Hung, Tim Akhurst, Ramin Alipour, Cherie Chiang, Rodney J Hicks, Michael S Hofman, Aravind S Ravi Kumar, Nirupa Sachithanandan, Javad Saghebi, Michael Michael, Grace Kong
Format: Article
Language:English
Published: Bioscientifica 2024-11-01
Series:Endocrine Oncology
Subjects:
ectopic cushing’s syndrome
neuroendocrine neoplasms
peptide receptor radionuclide therapy
radionuclide therapy; theranostics
Online Access:https://eo.bioscientifica.com/view/journals/eo/4/1/EO-24-0013.xml
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://eo.bioscientifica.com/view/journals/eo/4/1/EO-24-0013.xml

Similar Items